Results 181 to 190 of about 36,261 (308)
China's Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership. [PDF]
Babul A, Mahdavi P, Hussain M, Babul N.
europepmc +1 more source
ESG Controversies in Global Firms: A Black Mark?
ABSTRACT Despite increasing attention paid by companies to sustainability, there is still evidence of environmental, social and governance (commonly referred to as ESG) scandals. As research on this topic is scant, this paper aims to analyse the impact of ESG controversies on firms' sustainability practices, that is, ESG policies, as well as ...
Beatrice Bais, Guido Orzes, Marco Sartor
wiley +1 more source
Impact of China's Drug Regulatory Reforms on the Development of Anti-Tumor Drugs. [PDF]
Tang L, Yuan L, Geng Y, Yang Z, Huang G.
europepmc +1 more source
Understanding multinational companies in public health systems, using a competitive advantage framework. [PDF]
Lethbridge J.
europepmc +1 more source
Beyond Closed Loops: Advancing Climate Change Mitigation by Collaborative Open Approaches
ABSTRACT Even as world leaders emphasize the urgency of limiting global warming, a slow transition to a circular economy persists. While climate mitigation efforts focus on renewable energy and efficiency measures, addressing the 45% of emissions from product manufacturing remains critical.
Anna‐Kristin Behnert +2 more
wiley +1 more source
Canadian mines, global issues: examining health impacts, demanding action. [PDF]
Spitzer DL +7 more
europepmc +1 more source
ABSTRACT Despite growing interest in corporate relocation decisions and sustainability, the existing literature is limited in its consumer‐centric approach. Integrating social exchange theory and construal level theory, this research investigates how consumers perceive sustainability‐driven nearshoring motives (i.e., socio‐economic vs.
Cagla Dayangan +2 more
wiley +1 more source
Defining Remanufacturing: A Key Business Strategy Advancing Industrial Circularity
ABSTRACT Remanufacturing is a key strategy in the circular economy, enabling substantial product value retention. However, inconsistent definitions across standards and legislation hinder global trade, core recovery and market acceptance. This study examines how remanufacturing is defined in laws and standards, and how these definitions impact industry
Erik Sundin +2 more
wiley +1 more source
Mapping the rare disease stakeholders in India. [PDF]
Chakraborty Choudhury M +2 more
europepmc +1 more source
Supply Chain Network, ESG Scores and Financial Performance
ABSTRACT This paper provides novel evidence on the role of supply chain networks in influencing firms' environmental, social and governance (ESG) scores and financial performance. Our analysis employs financial, board, ESG and supply chain data, resulting in an unbalanced panel of over 16,000 firm‐year observations from 3028 publicly traded US firms ...
Michail Filippidis +2 more
wiley +1 more source

